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ABSTRACT 25 
BACKGROUND/OBJECTIVES: Obesity is common following hypothalamic damage due to tumours. 26 
Homeostatic and non-homeostatic brain centres control appetite and energy balance but their interaction in 27 
the presence of hypothalamic damage remains unknown. We hypothesized that abnormal appetite in obese 28 
patients with hypothalamic damage results from aberrant brain processing of food stimuli. We sought to 29 
establish differences in activation of brain food-motivation and reward neurocircuitry in patients with 30 
hypothalamic obesity (HO) compared to patients with hypothalamic damage whose weight had remained 31 
stable. 32 
SUBJECTS/METHODS: In a cross-sectional study at a University Clinical Research Centre, we studied 9 33 
patients with HO, 10 age-matched obese controls (OC), 7 patients who remained weight-stable following 34 
hypothalamic insult (HWS), and 10 non-obese controls (NOC).  Functional magnetic resonance imaging was 35 
performed in the fasted state, 1 h and 3 h after a test meal, while subjects were presented with images of 36 
high-calorie foods, low-calorie foods and non-food objects. Insulin, GLP-1, PYY and ghrelin were measured 37 
throughout the experiment and appetite ratings recorded. 38 
RESULTS: Mean neural activation in the posterior insula and lingual gyrus (brain areas linked to food 39 
motivation and reward value of food) in HWS were significantly lower than in the other 3 groups (P = 40 
0.001). A significant negative correlation was found between insulin levels and posterior insula activation (P 41 
= 0.002). 42 
CONCLUSIONS: Neural pathways associated with food motivation and reward-related behaviour, and the 43 
influence of insulin on their activation, may be involved in the pathophysiology of HO. 44 
 45 
 46 
 47 
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INTRODUCTION 48 
Weight gain and obesity are common sequelae of hypothalamic damage secondary to e.g. hypothalamic 49 
tumours or craniopharyngiomas.1,2 Hypothalamic obesity (HO) is an acute weight gain following such 50 
damage despite adequate treatment of associated hormone deficiencies, and is typically clinically significant, 51 
difficult to predict and refractory to treatment. The neurobiology of HO remains unclear. 52 
Control of appetite depends on interacting homeostatic and non-homeostatic (cognition, emotion and reward) 53 
systems.3 The main homeostatic brain regions regulating feeding and body weight are the hypothalamus, 54 
brainstem (especially the midbrain ventral tegmental area [VTA]) and nucleus accumbens, while the cortico-55 
limbic and higher cortical regions are important in the processing of environmental cues, the hedonic drive to 56 
eat and the rewarding properties of food. The interactions between these two systems in humans remain 57 
poorly characterized. Functional brain imaging (fMRI) has been used to explore these by identifying brain 58 
areas that are differentially activated by alteration of the feeding state under different clinical and 59 
experimental conditions.  60 
We hypothesized that abnormal appetite in HO results from aberrant processing of food stimuli in the neural 61 
pathways that guide reward-related behaviour, and which may assume a dominant role following 62 
hypothalamic damage. Our main objective was to establish differences in activation of food-motivation and 63 
reward neurocircuitry in HO compared to patients whose weight had remained stable following 64 
hypothalamic injury, using fMRI to measure brain responses to visual food stimuli before and after a 65 
standardized meal.  66 
 67 
SUBJECTS AND METHODS 68 
Participants 69 
We studied 36 participants: 9 obese patients with hypothalamic damage (HO), 7 weight-stable non-obese 70 
patients with hypothalamic damage (HWS), and 20 healthy BMI-matched volunteers [10 non-obese controls 71 
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(NOC) and 10 obese controls (OC)] of similar age and sex. Patients were recruited from specialist 72 
neuroendocrine clinics in Liverpool, UK. All had undergone treatment for hypothalamic tumours or adjacent 73 
tumours compressing or invading the hypothalamus (9 pituitary macroadenomas, 6 craniopharyngiomas and 74 
1 hypothalamic glioma), with hypothalamic damage determined by a neuroradiologist. HO was defined as 75 
body mass index (BMI) ≥30 kg/m2 at latest clinical follow-up which had increased 2 kg/m2 since tumour 76 
diagnosis. HWS patients had BMI <30 kg/m2 which had not increased >2 kg/m2 since diagnosis. All patients 77 
were on adequate pituitary hormone replacement therapy; based on standard dynamic endocrine testing 12 78 
patients had cortisol deficiency and were receiving hydrocortisone, 10 had secondary hypothyroidism treated 79 
with thyroxine and 6 had permanent central diabetes insipidus treated with desmopressin; all pre-menopausal 80 
women with secondary hypogonadism were on hormone replacement therapy and 6 hypogonadal male 81 
patients were treated with testosterone. Fourteen patients had severe growth hormone deficiency of whom 12 82 
were receiving replacement therapy, the other two, being asymptomatic as assessed by the QOL-AGHDA 83 
questionnaire, did not qualify for treatment under UK guidelines. Healthy volunteers were recruited by 84 
advertisement and categorised as obese if BMI ≥30 kg/m2. The study was approved by the Northwest 85 
Research Ethics Committee, 09/H1001/4. Written informed consent was obtained from each participant.  86 
 87 
Study design  88 
Participants fasted from 2200 the previous night and underwent fMRI at 0900. Blood samples were collected 89 
before the baseline scan, following which participants consumed a breakfast meal of porridge and orange 90 
juice constituting 25% of calculated basal metabolic rate. fMRI was repeated 1 h after breakfast after which 91 
participants rested quietly for 2 h undergoing blood sampling and appetite assessment. fMRI was performed 92 
again 3 h after breakfast. Blood samples were taken before and 15, 30, 60, 120 and 180 min after breakfast 93 
and at the end of all scanning, for measurement of insulin, glucagon-like peptide-1 (GLP-1), ghrelin, and 94 
Peptide YY (PYY). Visual Analogue Scale (VAS) ratings of hunger, fullness, and desire to eat were 95 
completed by the participants in the fasting state and at the end of each scanning session.  96 
 97 
MRI acquisition 98 
MR images were obtained using a Siemens 3 Tesla Trio (Erlangen, Germany) and eight-channel head coil. 99 
fMRI used echoplanar EPI (TR 3000 ms, TE 30 ms, flip angle 90˚, FOV 192×192 mm2, 56 oblique 2 mm 100 
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slices with slice gap 0.8 mm, voxel 3×3×3 mm3). Whole brain anatomical T1-weighted MRI used MDEFT 101 
(TR7.92 ms, TE 2.48 ms, flip angle 16˚, FOV 256×240, 180 1mm slices, voxel 1×1×1 mm3). 102 
 103 
fMRI activation task 104 
The task presented images of high-calorie foods (e.g. sausage rolls, doughnuts), low-calorie foods (e.g. 105 
steamed salmon with vegetables, mixed fruit salad) or non-food objects (e.g. shoes, toy cars, cycle helmet). 106 
Food photographs were included based on a questionnaire where participants were asked if the food shown 107 
was high or low energy, and to rate its pleasantness (hedonic value); photographs included were those with 108 
the greatest agreement on energy content and judged the most pleasant. Images were presented using 109 
Presentation software (https://nbs.neuro-bs.com). Each block of 4 lasted 16 s and consisted of either high-110 
calorie foods, low-calorie foods, or non-food objects, with a 6 s rest period showing a fixation cross between 111 
blocks. Each condition (high-calorie foods, low-calorie foods, objects) appeared once per cycle in random 112 
order, for a total of 8 cycles, with no duplication of images (Figure 1).  113 
 114 
 115 
Image analysis  116 
Pre-processing and statistical analyses used SPM8 (Statistical Parametric Mapping software package, 117 
Wellcome Department of Cognitive Neurology, London, UK: http://www.fil.ion.ucl.ac.uk/spm). Slice-timing 118 
correction was followed by realignment to correct for head movement. A mean functional image was 119 
constructed from the realigned images for each participant, and co-registered to the Montreal Neurological 120 
Institute (MNI) EPI template in SPM8. The resulting pixel size in standard stereotaxic coordinates was 2×2 121 
mm2, with interplane distance 2 mm. The normalized images were smoothed with an isotropic Gaussian 122 
kernel of 6×6×6 mm3 FWHM to compensate for variations in brain size and gyral pattern. 123 
 124 
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Biochemical measurements 125 
All samples were assayed in duplicate in one batch. Blood for measurement of GLP-1, PYY and ghrelin was 126 
collected in tubes containing 50 µl aprotinin to prevent proteolytic degradation, centrifuged at -4°C and 127 
plasma stored for analysis at -80°C. Insulin was measured using a Siemens Immulite 2000 Immunoassay. 128 
Active GLP-1 and active ghrelin were measured using commercial enzyme-linked immunoassays (ELISA) 129 
(Millipore, Billerica, USA); the standard curve range for GLP-1 was 0.8-100 pmol/l and inter- and intra-130 
assay precisions were 8% and 7% respectively, while the corresponding range for ghrelin was 10-2000 pg/ml 131 
and inter- and intra-assay precisions were 10-16% and 7-10%. PYY (3-36) was measured using a 132 
commercial ELISA (Phoenix Pharmaceuticals Inc, Burlingame, USA); standard curve range was 0.06-100 133 
ng/ml. 134 
 135 
Statistical analyses 136 
The smoothed normalised functional images were included in the first level design matrix in SPM8. For each 137 
participant, the contrast between all foods and objects was selected to remove activation related to visual 138 
perception and object recognition. The resulting single contrast images (1 per participant) were entered into a 139 
one-sample t-test (second level analysis) to determine activation to all foods across all subjects. Results were 140 
corrected for multiple comparisons using a false discovery rate (FDR) of P≤0.05 and a cluster size of k ≥20. 141 
Regions of interest (ROIs) were defined using MarsBaR (http://marsbar.sourceforge.net/); only ROIs with 142 
cluster size k 3000 voxels were used in subsequent analysis. The 6 significant clusters are shown in Table 143 
1. Contrast values for high- and low-calorie foods in each of these 6 ROIs were defined using MarsBaR for 144 
each of the 3 sessions using each participant’s first level design matrix, generating 6 contrast values per 145 
participant. Subsequent statistical analysis was performed in SPSS v.17. Six linear mixed-effects models 146 
were performed for the 6 activation clusters. For each, ROI contrast values for high- and low-calorie foods 147 
for each of the 3 sessions were entered as the outcome variable. The grouping factors weight stable 148 
(NOC+HWS) vs. obese (OC+HO), controls (NOC+OC) vs. patients (HWS+HO) and the interaction 149 
between these were entered as predictor variables along with the variables session (fasting, 1 h and 3 h post 150 
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meal) and high/low-calorie foods. To analyse contributions of age, sex and other variables to effects of 151 
grouping factors, two-way analyses of covariance (ANCOVA) were performed with select brain activations 152 
as dependent measures and age, sex, PYY, BMI and VAS scores as covariates. 153 
Areas under the curve (AUC) for ghrelin, GLP-1, PYY and insulin responses were calculated by trapezoidal 154 
integration using GraphPad Prism-5 software. A linear mixed-effects model was performed using the 155 
outcome variable ghrelin AUC and the predictor variables weight-stable vs. obese group, control vs. patient 156 
group, and session (at 3 levels). Similar models were performed using outcome variables GLP-1 AUC, PYY 157 
AUC and insulin AUC and the VAS ratings hunger, fullness and desire to eat. P<0.05 (two-tailed) was taken 158 
as significant.  159 
 160 
RESULTS 161 
Nine patients with HO [mean (SD) BMI 37.7(5.4) kg/m2, age 47(15) y], 10 age-matched obese controls (OC) 162 
[BMI 38(6) kg/m2], 7 patients who remained weight-stable following hypothalamic insult (HWS) [BMI 163 
26.9(2.3) kg/m2, age 57(17) y], and 10 age-matched non-obese controls (NOC) [BMI 26(3) kg/m2] were 164 
studied. 165 
 166 
fMRI data 167 
Effects of picture types (high- and low-calorie foods, objects) 168 
 Across all participants and scanning sessions there were 6 ROIs with significantly greater activation for food 169 
images compared to objects (Table 1): left-hemisphere posterior insula and middle frontal gyrus, and right-170 
hemisphere lingual gyrus, precentral gyrus, anterior cingulate and posterior cingulate gyrus. Mean activation 171 
across the 6 regions for high- and low-calorie foods is given for each of the 4 groups in Table 2. The 172 
activation maps are shown in Figure 2.  173 
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No significant effect was found for high/low-calorie foods in any of the 6 linear mixed effects 174 
models (P>0.05). Potential interactions between patient/control group, lean/obese group and 175 
high/low-calorie foods were considered in each model by adding the product of the corresponding 176 
two variables as an additional explanatory variable; none significantly improved the fit (P>0.05) 177 
and were subsequently excluded. 178 
 179 
Between-group comparison 180 
In 5 of these 6 brain areas obese participants (HO+OC) showed greater activation in response to high-calorie 181 
foods than non-obese participants (HWS+NOC) (Table 2). Box plots for each of the 6 ROIs separated by 182 
patient/control and lean/obese group are shown in Figure 3.  183 
The linear mixed-effects model showed a significant difference in activation of the lingual gyrus (P=0.001; 184 
coefficient -0.34, SE 0.1, 95% CI: -0.53, -0.15) and posterior insula (P=0.001; coefficient -0.2, SE 0.06, 95% 185 
CI: -0.33, -0.08) between weight-stable (HWS+NOC) vs. obese (HO+OC) groups. The activation cluster 186 
in insula, having spatial maximum in posterior insula, also spread to middle insular cortex. The 187 
interaction between the groups weight-stable (HWS+NOC) vs. obese (HO+OC) and controls (NOC+OC) vs. 188 
patients (HO+HWS) was significant for lingual gyrus (P<0.001; coefficient 0.47, SE 0.13, 95% CI: 0.22, 189 
0.73) and posterior insula (P=0.028; coefficient 0.19, SE 0.08, 95% CI: 0.02, 0.35). Activation for both high- 190 
and low-calorie foods in lingual gyrus and posterior insula was weaker in HWS than in HO and controls 191 
(OC+NOC) (Table 2).  192 
None of the covariates (age, sex, PYY, BMI or VAS scores) showed significant covariation in either 193 
posterior insula or lingual gyrus. Further, the interaction effects were significant even with inclusion of 194 
covariates. We conclude that the interactions between weight-stable (HWS+NOC) vs. obese (HO+OC) and 195 
controls vs. patients seen in posterior insula and lingual gyrus were not caused by individual or group 196 
differences in age or other variables. 197 
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Post-hoc pair-wise comparisons were performed for the variable session (at 3 levels: fasted, 1 h and 3 h post-198 
meal) in each linear mixed-effects model. Session was significant for lingual gyrus (F(2, 138)=4.542, P=0.012), 199 
posterior insula (F(2,151)=3.024, P=0.05) and posterior cingulate gyrus (F(2,148)=3.556, P=0.03). Pair-wise 200 
comparisons revealed a significant difference in activation across posterior insula between the fasted state 201 
and 3 h post-meal (P=0.04; mean difference 0.12, SE 0.06, 95%CI: 0.004,0.23) and between 1 h and 3 h 202 
post-meal (P=0.05; mean difference 0.09, SE 0.05, 95%CI: -0.001,0.18), with greater activation in the fasted 203 
state and 1 h compared to 3 h post-meal. Across all groups, activation of the lingual gyrus in the visual 204 
cortex was greater fasted compared to 3 h post-meal (P=0.003; mean difference 0.24, SE 0.8, 95%CI: 0.08, 205 
0.40). Activation was weaker in the posterior cingulate gyrus in the fasted state compared to 1 h post-meal 206 
(P=0.012; mean difference -0.15, SE 0.06, 95%CI: -0.27,-0.034). 207 
The linear mixed-effects models showed a significant effect for control vs. patient group where ghrelin was 208 
the outcome variable (F(1,27)=5.245, P<0.03), with patients (HO+HWS) having higher ghrelin than controls 209 
(OC+NOC) (coefficient -1.06, SE 0.5, 95% CI: -2.0, -0.1); this group effect was not significantly associated 210 
with levels of PYY, GLP-1 or insulin (P>0.05). The effect weight-stable vs. obese group was statistically 211 
significant for the model where PYY was the outcome variable (F(1,27)=8.99, P=0.006), with obese 212 
individuals having higher PYY than weight-stable individuals (coefficient -0.24, SE 0.1, 95% CI: -0.4,-0.1); 213 
this group effect was not significantly associated with levels of GLP-1, ghrelin or insulin (P>0.05).  214 
 215 
Relationship between insula activation and hormonal parameters 216 
ANCOVA was used to assess activation across the insula cortex while controlling for ghrelin, GLP-1, PYY 217 
and insulin. Predictor variables were selected stepwise. Only insulin was significantly associated with 218 
posterior insula activation (P=0.04), with negative significant correlation between insulin level and posterior 219 
insula activation (ß = -0.004, P=0.002) such that a 1 U/l increase in insulin corresponds to a 0.004 decrease 220 
in insula activation. Insulin AUC for the four subject groups is shown in Figure 4. 221 
 222 
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Appetite VAS ratings 223 
Results from the linear mixed-effects models showed higher VAS ratings for hunger (P<0.05; coefficient 224 
8.37, SE 4.3) and desire to eat (P=0.04; coefficient 9.01, SE 4.3, 95% CI: 0.45,17.6) in obese participants 225 
(HO+OC) compared to non-obese (HWS+NOC) throughout the whole experiment irrespective of presence 226 
of hypothalamic damage. 227 
 228 
DISCUSSION 229 
Viewing high-calorie food-related stimuli, weight-stable patients with hypothalamic damage (HWS) showed 230 
significantly less brain activation in regions linked to processing of interoceptive inputs and modulation of 231 
food motivation behaviour (e.g., the posterior and middle insula),
4
 and in regions linked to reward value for 232 
food (e.g the lingual gyrus). In patients with HO, enhanced activation of food motivation and reward 233 
neurocircuitry is accompanied by increased hunger and desire to eat, potentially influencing food-seeking 234 
behaviour and leading to higher food intake than patients who do not gain significant weight. In both these 235 
groups (HO and HWS) the hypothalamic centre of energy homeostasis is damaged. Our findings suggest that 236 
in the HWS patients there may be greater preservation of the functional and anatomical connectivity between 237 
the brain food reward processing network and the extra-hypothalamic homeostatic neurocircuitry (such as 238 
the midbrain VTA and the nucleus accumbens) allowing a more coordinated response between the 239 
homeostatic and reward networks that regulate feeding behaviour and energy balance. 240 
Of the 6 brain regions with significantly greater activation when viewing food images compared to objects, 2 241 
regions (insula and anterior cingulate cortex [ACC]) were first described in Tataranni’s seminal PET study 242 
of hunger and satiety in humans5 and have been identified in multiple studies since. The lingual gyrus 6 has 243 
also been identified as important in neuroimaging studies of obesity. Some of these regions determine the 244 
incentive/reward value of food,7,8,9 some are linked to meal termination5,10 and satiation,5 and some with 245 
liking.10 Further studies have shown differential activation patterns in these brain regions in obese compared 246 
to lean participants.11,15  247 
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The greater activation in the lingual gyrus (which has been linked to the reward value of food) we observed 248 
in response to high-calorie foods in all groups compared to HWS accords with a previous PET finding11 that 249 
obese males have greater decrease in regional cerebral blood flow in this region compared to lean following 250 
satiation with a liquid meal. Also consistent with our findings, Rothemund et al12 found increased activation 251 
in the left lingual gyrus (and also the insula) when viewing high-calorie foods, in obese compared to lean 252 
individuals.  253 
The posterior insular cortex is critical in appetite and feeding, and has connections with the thalamus,13,14 254 
hypothalamus,13 orbitofrontal cortex,14 prefrontal cortex (PFC) and amygdala. Posterior insula activity has 255 
been reported to increase with hunger5,8,9 and decrease with satiation11,15 and overfeeding16 by decreasing the 256 
perceived salience/reward value of food stimuli.10,17  257 
The insula promotes food intake and is inhibited by areas involved in meal termination, such as the PFC.11,15 258 
In our HWS group its connections with other important brain areas (especially the extra-hypothalamic 259 
homeostatic neurocircuitry such as the VTA and the nucleus accumbens) may have been better preserved 260 
following hypothalamic damage; this may explain the pattern of activation in insula in response to high-261 
calorie food stimuli, which is similar to the pattern previously observed, including in lean participants .11,15 262 
Our finding of greater insula activation in HO compared to HWS agrees with findings in obese compared to 263 
lean cohorts without hypothalamic damage.11,12,15,18  264 
The neurochemical/neuroendocrine processes underlying this differential pattern of brain activation in insula 265 
and lingual gyrus in patients who remain weight-stable compared with those who develop HO, remain 266 
speculative. The significant covariance effect between posterior insula activation decreases and increased 267 
insulin, which accords with a previous PET study,5 is suggestive. There is animal evidence that insulin acts 268 
centrally to reduce the reward properties of food,19 and intranasal insulin administration reduces food intake 269 
in humans,20 suggesting that it may facilitate long-term regulation of food intake and energy balance by 270 
acting as an anorectic signal. Notably, insulin increases neuronal firing in the insula in rats,21 and intranasal 271 
insulin administration in healthy volunteers increases neuronal activation in the insula,22 a finding which 272 
differs from the present and previous studies,5 and points to a potential fractionation of brain responses to 273 
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insulin in the absence of an adequate peripheral insulin response. Our findings suggest that the insula 274 
responds differently to insulin signals in weight-stable (HWS) and obese hypothalamic patients (HO). 275 
Although insulin levels were similar in both groups (Figure 4), insular activation was greater in HO than 276 
HWS, perhaps suggesting a preserved negative association between plasma insulin level and insula 277 
activation in the latter. None of the changes of PYY, GLP-1 in the 4 groups were associated with the 278 
differential brain activation patterns observed in the 6 ROIs, and more specifically in the insula and lingual 279 
gyrus which emerged as the regions of hypoactivation in the HWS group. This does not support an 280 
aetiological role for these appetite and satiety-related signals in the pathogenesis of HO.  281 
PYY is a possible mediator of postprandial satiety. We have shown that HO patients have fasting levels of 282 
total PYY similar to obese controls,23 and fail to exhibit an immediate and sustained post-meal rise. 283 
Intriguingly, PYY levels were greater in the obese participants compared with the non-obese, in contrast to 284 
previous reports.24,25 Differences in experimental design, macronutrient and energy content of the test meals 285 
(which we based on individual calculated basal metabolic rate) may account for this disparity.  286 
Leptin acts on neural circuits governing food intake to diminish perception of food reward while enhancing 287 
the response to satiety signals.26,27 Although we found similar fasting leptin levels in HO and obese 288 
controls,23 it would be interesting to study differences in dynamic test-meal responses of circulating leptin 289 
between HO and HWS and their correlation with the differential patterns of activation in the insula and 290 
lingual gyrus. 291 
Our study has limitations. Previous studies have described a difference in insula activation between males 292 
and females following satiation,
28
 so our mixed gender groups may have obscured some differences between 293 
pre- and post-prandial time-points. Our stringent statistical threshold may have reduced the number of areas 294 
of significant between-group difference; however, it adds additional weight to our positive findings. Ideally, 295 
we would have used a homogenous patient group, with one underlying histological diagnosis, but the limited 296 
numbers of patients seen in any single centre made it necessary to accept a more heterogeneous patient 297 
group. Our study, however, used a reasonably physiological overnight fasting period, and the low- and high-298 
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calorie food photographs were of comparable hedonic value, taken on a standardized background, and with 299 
good visual variability.  300 
In summary, we have provided the first evidence that neural pathways associated with food motivation and 301 
reward-related behaviour in response to food are differentially activated in patients with HO and in those 302 
who do not experience weight gain after hypothalamic damage. We have not been able to demonstrate 303 
correlation of meal initiation and termination signals such as ghrelin, PYY and GLP-1 with brain activation 304 
patterns, although we have shown that high plasma insulin levels correlated strongly with a reduction in the 305 
perceived reward properties of food. It is clear that the insula and lingual gyrus are an integral part of the 306 
network of brain areas involved in processing food stimuli. A comparatively weak posterior insula and 307 
lingual gyrus activation in the HWS patients may ‘protect’ these individuals from weight-gain. Disentangling 308 
the neurochemical/neuroendocrine processes underlying this differential pattern of brain activation in the 309 
insula and lingual gyrus may help in understanding the mechanisms underpinning weight-gain both in HO 310 
and in simple obesity in the general population. Further research into the pathophysiology of weight-gain in 311 
this interesting group of patients is encouraged, potentially in a large multi-centre study.  312 
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FIGURE LEGENDS 398 
Figure 1 Schematic representation of the block experimental design. Each rectangle represents a 16 399 
sec period during which 4 pictures of the same category have been presented for 4 s each. 400 
Figure 2 Neuronal activation across the 6 ROIs for the contrast high- and low-calorie foods vs. 401 
objects. Regions are shown in sagittal, coronal and axial planes, rendered on the surface of a single-402 
subject template supplied by SPM8. Talairach coordinates are given (x, y, z) for the most 403 
significant voxel in the cluster. L = left hemisphere, R = right hemisphere. Colour corresponds to T-404 
scores.  405 
Figure 3 Box plots displaying neuronal activation in each of the 6 ROIs in response to high-calorie 406 
foods (as an average of all 3 sessions) in each of the 4 subject groups (from left to right): NOC, 407 
non-obese controls; OC, obese controls; HWS, weight-stable patients with hypothalamic damage; 408 
HO, obese patients with hypothalamic damage. Light grey bars represent weight-stable groups 409 
(HWS+NOC), dark grey bars obese groups (HO+OC).  410 
Figure 4 Box plots for integrated (AUC) GLP-1 (pmol/l), PYY (ng/ml), ghrelin (pg/ml) and insulin 411 
(mIU/ml) measurements in each of the 4 subject groups (from left to right): NOC, non-obese 412 
controls; OC, obese controls; HWS, weight-stable patients with hypothalamic damage; HO, obese 413 
patients with hypothalamic damage. Light grey bars represent weight-stable groups (HWS+NOC) 414 
dark grey bars obese groups (HO+OC). 415 




Table 1. Regions of interest (ROIs) where activation is significantly greater for all food 
images than objects, across all participants 
Region 
Nearest 
BA 
Talairach 
coordinates  
Cluster 
volume 
(mm
3
) 
T-score 
Lingual gyrus (R) 18 6 -88 -4 52640 11.37 
Posterior insula (L) 13 -38 -4 4 12448 8.0 
Anterior cingulate gyrus (R) 32 2 18 42 45752 7.10 
Precentral gyrus (R) 21 66 -16 34 4640 6.18 
Posterior cingulate gyrus (R) 32 4 -28 32 17336 5.71 
Middle frontal gyrus (L) 46 -42 38 22 6736 4.7 
Talairach coordinates (x, y, z) are given for the most significant voxel in the cluster, while the 
regions of activation cover larger areas than those described. Abbreviations: BA = Brodmann 
area, L = left hemisphere, R = right hemisphere. 
 
1 
 
Table 2. Mean activation (SD) and [minimum, maximum] activation values within each ROI for 
high-calorie foods compared to objects and low-calorie foods compared to non-food objects in the 4 
groups  
Area 
 
High/low-
calorie foods 
 
HWS HO NOC OC 
Lingual gyrus 
(R) 
High 1.31 (0.42) 
[0.61,2.26] 
1.64 (0.49) 
[-0.93,2.5] 
1.7 (0.58) 
[0.81,2.96] 
1.61 (0.25) 
[1.12,2.08} 
Low 1.34 (0.42) 
[0.61,2.22] 
1.78 (0.57) 
[0.86,2.74] 
1.78 (0.53) 
[1.14,3.07] 
1.61 (0.40 
[0.46,2.51] 
Posterior insula 
(L) 
High -0.04 (0.27) 
[-0.66,0.58 
0.28 (0.53) 
[-0.34,2.05] 
0.19 (0.2) 
[-0.24,0.77] 
0.18 (0.28) 
[-0.54,0.92] 
Low -0.03 (0.25) 
[-0.59,0.39] 
0.22 (0.58) 
[-0.16,2.45] 
0.21 (0.17) 
[-0.23,0.44] 
0.22 (0.35 
[-0.33,1.58] 
Anterior 
cingulate gyrus 
(R) 
High 0.08 (0.19) 
[-0.33,0.38] 
0.19 (0.25) 
[-0.34,0.66] 
0.02 (0.24) 
[-0.49,0.49] 
0.14 (0.26) 
[-0.6,0.82] 
Low 0.12 (0.19) 
[-0.29,0.52] 
0.14 (0.19) 
[-0.42,0.46] 
0.11 (0.22) 
[-0.42,0.49] 
0.12 (0.23 
[-0.26,0.98] 
Precentral 
 gyrus (R) 
High 0.09 (0.47) 
[-0.7,0.85] 
0.18 (0.51) 
[-0.76,1.21] 
0.07 (0.29) 
[-0.47,0.8] 
0.1 (0.4) 
[-0.67,1.17] 
Low 0.21 (0.28) 
[-0.16,0.8] 
0.05 (0.56) 
[-1.1,1.17] 
0.12 (0.28) 
[-0.74,0.63] 
0.08 (0.27 
[-0.44,0.79] 
Posterior 
cingulate gyrus 
(R) 
High -0.05 (0.33) 
[-0.6,1.05] 
0.11 (0.54) 
[-1.02,1.62] 
-0.12 (0.19) 
[-0.5,0.21] 
0.07 (0.41) 
[-0.46,1.4] 
Low 0.01 (0.27) 
[-0.53,0.5] 
0.1 (0.42) 
[-0.55,1.44] 
-0.08 (0.20) 
[-0.54,0.24] 
0.09 (0.38 
[-0.52,1.43] 
Middle frontal 
gyrus (L) 
High 0.12 (0.22) 
[-0.32,0.52] 
0.22 (0.45) 
[-0.68,1.36] 
-0.002 (0.3) 
[-0.59,0.84] 
0.13 (0.41) 
[-0.69,1.42] 
Low 0.15 (0.29) 
[-0.43,0.66] 
0.21 (0.4) 
[-0.3,1.45] 
0.15 (0.31) 
[-0.47,0.97] 
0.16 (0.42 
[-0.44,1.76] 
ROI, region of interest; HO, obese patients with hypothalamic damage; OC, obese controls; HWS, 
weight-stable patients with hypothalamic damage; NOC, non-obese controls; R, right hemisphere; 
L, left hemisphere 
 
